Pharmaceutical composition for treating peptic ulcers
What is AI technical title?
AI technical title is built by Patsnap AI team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the direction of drug combination, digestive system, medical formula, etc., can solve problems such as high price, large side effects, and long healing time
Inactive Publication Date: 2015-12-30
CHENGDU HENGLING TECH CO LTD
View PDF5 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] The current medicines for treating the above diseases are mostly chemical medicines, which are expensive, have large side effects, and take a long time to cure
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] Example 1 Preparation of the medicine of the present invention
[0031] Atractylodes 10g, Poria 10g, Chixiaodou 10g, Astragalus 7.5g, Yinchen 7.5g, Dandelion 7.5g, Bitter almond 5g, Platycodon 5g, Patchouli 5g, Dried ginger 2.5g, Ginseng 2.5g; add water and cook 3 times, the first Add 12 times the amount of water for 10 minutes, add 8 times the amount of water for 30 minutes, add 10 times the amount of water for 30 minutes, filter, and combine the water decoction to obtain the medicine of the present invention .
Embodiment 2
[0032] The preparation of embodiment 2 medicine of the present invention
[0033] Atractylodes 180g, Poria 220g, Chixiaodou 220g, Astragalus 170g, Yinchen 170g, Dandelion 170g, Bitter almond 120g, Platycodon 120g, Patchouli 120g, Dried ginger 60g, Ginseng 60g; add water and boil 3 times, the first time adding 15 times Decoct with water for 20 minutes, add 10 times the amount of water for 60 minutes for the second time, add 10 times the amount of water for 60 minutes for the third time, filter and combine the water decoction to obtain the medicine of the present invention.
Embodiment 3
[0034] The preparation of embodiment 3 medicine of the present invention
[0035] Atractylodes 260g, Poria 140g, Chixiaodou 140g, Astragalus 105g, Yinchen 105g, Dandelion 105g, Bitter almond 70g, Platycodon 70g, Patchouli 70g, Ginger 35g, Ginseng 35g. Add water and cook for 3 times, the first time add 12 times the amount of water and cook for 20 minutes, the second time add 10 times the amount of water and cook for 60 minutes, the third time add 8 times the amount of water and cook for 30 minutes, filter, combine with water and cook After the liquid, the medicine of the present invention is obtained.
[0036] The beneficial effects of the present invention are further shown below through specific test examples.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a pharmaceutical composition for treating peptic ulcers. The pharmaceutical composition comprises, by weight, 7-13 parts of bighead atractylodes rhizomes, 7-13 parts of poria cocos, 7-13 parts of phaseolus calcaratus, 5-10 parts of astragalus membranaceus, 5-10 parts of capillary wormwood herbs, 5-10 parts of dandelion, 3-7 parts of bitter almonds, 3-7 parts of platycodon grandiflorum, 3-7 parts of pogostemon cablin, 2-3 parts of rhizoma zingiberis and 2-3 parts of ginseng. The pharmaceutical composition has the advantages that the pharmaceutical composition plays a synergistic interaction role and can treat gastric ulcers, duodenal ulcers and erosive gastritis effectively after reasonable compatibility, and a new medication choice is provided for clinical peptic ulcer treatment.
Description
technical field [0001] The present invention relates to a pharmaceutical composition for treating peptic ulcer. Background technique [0002] Gastric and duodenal ulcers refer to the localized circular or oval full-thickness defects of the gastric and duodenal mucosa. The muscularis mucosa is penetrated, and fibrous scars are inevitably left after healing, and the surface is a layer of epithelium. Covered, the muscularis mucosa cannot regenerate. The etiology can be summed up as the self-digestion of gastric mucosa by gastric acid and pepsin or the destruction of gastric mucosal barrier due to various reasons. In recent years, it is believed that the formation of ulcers also has an important relationship with the infection of Helicobacter pylori in the stomach. [0003] Chronic erosive gastritis, also known as verrucous gastritis or pox-like gastritis, generally only see indigestion symptoms such as fullness after meals, pantothenic acid, belching, and irregular abdominal ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More